The Erbitux market is witnessing steady growth over the forecast period, supported by growing cancer patient pool, increased focus on biomarker driven therapy.
Read More
The Epoetin Alfa market is witnessing steady growth over the forecast period, supported by expansion of biosimilar epoetin products, growing geriatric population.
Read More
The Epkinly market is witnessing steady growth over the forecast period, supported by growing adoption of immuno-oncology therapies, expanding clinical indications for bispecific antibodies.
Read More
The Entyvio market is witnessing steady growth over the forecast period, supported by increasing global ibd prevalence, expansion into earlier treatment lines.
Read More
The Enspryng market is witnessing steady growth over the forecast period, supported by expansion of biologics in neurology, increasing diagnosis of rare demyelinating diseases.
Read More
The Enjaymo market is witnessing steady growth over the forecast period, supported by expansion of complement inhibitor pipelines, increasing awareness of rare hemolytic diseases.
Read More
The Enhertu market is witnessing steady growth over the forecast period, supported by expanding indications for antibody drug conjugates, growth in her2 testing adoption.
Read More
The Engerix-B market is witnessing steady growth over the forecast period, supported by expansion of adult vaccination programs, rising focus on healthcare worker safety.
Read More
The Enbrel Mini market is witnessing steady growth over the forecast period, supported by rising demand for self administered biologics, increasing autoimmune disease burden.
Read More
The Enbrel (Etanercept) market is witnessing steady growth over the forecast period, supported by increasing competition from biosimilars, rising demand for cost-effective biologic therapies.
Read More